Moderna Stock
-
Merck, Moderna show progress on skin cancer vaccine using same technology as COVID shotsThe patient group that took the potential skin cancer vaccine and Keytruda saw a 44 per cent reduction in the risk of death or the cancer returning, the companies said.HealthDec 13, 2022
-
Moderna says its Omicron shots provide better protection than original COVID-19 jabModerna, however, said levels of neutralizing antibody response dropped nearly five-fold against the emerging sub-variant BQ.1.1 when compared with BA.4/5.WorldNov 14, 2022
-
Moderna shares drop as company cuts COVID-19 vaccine sales forecast on supply woesSome U.S. pharmacies in September had reported that government supply of Moderna's updated shot remains limited, causing appointments for the product to vary across the country.WorldNov 3, 2022
![]()
-
Moderna to set up Africa’s first mRNA vaccine manufacturing facilityModerna said it expects to invest about $500 million in the Kenyan facility and supply as many as 500 million doses of mRNA vaccines to the continent each year.WorldMar 7, 2022
![]()
-
Moderna struggles with COVID-19 vaccine ramp-up, cuts 2021 sales forecastModerna's sales target cut is in sharp contrast to that of larger rival Pfizer Inc, which earlier this week raised its sales forecast for its COVID-19 shot.MoneyNov 4, 2021
![]()
-
Moderna co-founder says Canada needs focused funds to grow domestic biotechModerna's Canadian co-founder says politicians often try to be equitable with their funding pledges to hit every region of the country -- but it's not always the right strategy.HealthOct 28, 2021
![]()
-
U.S. IP waiver support rocks COVID-19 vaccine makersPfizer, Moderna, Novavax and U.S. shares of BioNTech were down between four per cent and 10 per cent on Thursday.MoneyMay 6, 2021
![]()
-
Moderna’s coronavirus vaccine shows signs of success in early-stage trialThe company's vaccine is at the forefront of the efforts in developing a treatment for the fast-spreading virus.WorldMay 18, 2020
![]()
